搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 7 天
时间不限
过去 1 小时
过去 24 小时
过去 30 天
按时间排序
按相关度排序
来自MSN
1 小时
GLP-1 Drug Shortage Is Over. Why Might These Drugs Soon Be Costlier and Harder to Access?
After years of shortages, the Food and Drug Administration (FDA) has now listed Novo Nordisk’s blockbuster diabetes and ...
Crain's Chicago Business
9 小时
Behind burgeoning diabetes treatment, dueling UChicago and UIC profs
At the center of this fight is how the FDA regulates a possible "functional cure" for Type 1 diabetes and determines who gets ...
verywellhealth
1 天
What Research Says About Your Daily Sugar Consumption
A new study confirms the negative health effects of eating too much sugar and lays out exactly how much sugar you should ...
1 天
Novo Nordisk CEO warns of deaths linked to compounded semaglutide
The head of the company that makes the diabetes and obesity drugs Ozempic and Wegovy has warned that compounded versions of ...
1 天
Compounded semaglutide associated with at least 10 deaths, Novo Nordisk CEO warns
Compounded versions of semaglutide, the active ingredient in approved diabetes and obesity drugs Ozempic and Wegovy, have ...
2 天
Scientists Warn of Aging Effects of 'Harmless' Breakfast Foods
This includes packaged snacks, carbonated drinks, instant noodles, ready meals and most products that contain a long list of ...
News 8000
2 天
Active ingredient in diabetes and obesity drugs associated with at least 10 deaths, Novo ...
Compounded versions of semaglutide, the active ingredient in approved diabetes and obesity drugs Ozempic and Wegovy, have ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈